General Announcement::Press Release

Issuer & Securities

Issuer/ Manager
BIOCON BIOLOGICS GLOBAL PLC
Securities
BIOCONBIO US$800M6.67%N291009A - US090978AA56 - RJUB
BIOCONBIO US$800M6.67%N291009R - USG11185AA61 - KSEB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
08-May-2025 23:44:11
Status
New
Announcement Sub Title
Press Release
Announcement Reference
SG250508OTHRVZ2Z
Submitted By (Co./ Ind. Name)
Akhilesh Nand / Biocon Biologics Limited
Designation
Company Secretary
Effective Date and Time of the event
08/05/2025 21:00:00
Description (Please provide a detailed description of the event in the box below)
Press Release titled "Biocon Q4FY25 Revenue at Rs 4,454 Cr, Up 15%**, EBITDA at Rs 1,115 Cr; Up 16%; Net Profit at Rs 344 Cr, Up 153%, FY25 Revenue at Rs 16,470 Cr; EBITDA at Rs 4,374 Cr; Net Profit at Rs 1,013 Cr

Attachments

BBL_PR_Q4FY25_SGX_08052025.pdf
Total size =1281K